TapewireFind a company

person · Reporting owner

Watson David Hibbert

Disclosed activity across 1 company

Tapewire entity
37941
SEC CIK
0001482442

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ARGAN INCAGX · Entity 3828Director · PRESIDENT AND CEOJune 15, 2026June 16, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ARGAN INC

Report date June 15, 2026 · Filed June 16, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect40,005 Ending reported balance After 2026-06-16 transaction · row 5
5 source rows · reconciled sequence

Row 1 · 2026-06-15 · Sale · Disposed 9,993 · Balance 40,005

F1: On June 15, 2026, the Reporting Person sold 9,993 shares of the Issuer's common stock on the open market at an average price of $651.22 per share.

Row 2 · 2026-06-16 · Exercise / conversion · Acquired 862 · Balance 40,867

F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method.

Row 3 · 2026-06-16 · Exercise / conversion · Acquired 588 · Balance 41,455

F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method.

Row 4 · 2026-06-16 · Exercise / conversion · Acquired 430 · Balance 41,885

F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method.

Row 5 · 2026-06-16 · Sale · Disposed 1,880 · Balance 40,005

F5: On June 16, 2026 the Reporting Person sold 1,880 shares of the Issuer's common stock on the open market at an average price of $707.35 per share.

Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $39.47 · Expires 2033-04-17Direct4,415 Reported balance After 2026-06-16 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2026-06-16 · Exercise / conversion · Disposed 1,666 · Balance 4,415

F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method.

Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $61.22 · Expires 2034-04-16Direct3,415 Reported balance After 2026-06-16 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2026-06-16 · Exercise / conversion · Disposed 1,000 · Balance 3,415

F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method.

Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $148.72 · Expires 2035-04-16Direct2,748 Reported balance After 2026-06-16 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2026-06-16 · Exercise / conversion · Disposed 667 · Balance 2,748

F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method.

Filing footnotes · ownership attribution and instrument terms

F1: On June 15, 2026, the Reporting Person sold 9,993 shares of the Issuer's common stock on the open market at an average price of $651.22 per share.

F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method.

F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method.

F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method.

F5: On June 16, 2026 the Reporting Person sold 1,880 shares of the Issuer's common stock on the open market at an average price of $707.35 per share.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 16, 2026 Filed Jun 16, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionOption to Purchase Common Stock · Derivative 667 $148.72 Strike: $148.72 $99,196.24
Disclosure

SEC source: 0001482442-26-000012 · form4-06162026_040603.xml · derivative · entry 8

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,748

Underlying: Common Stock · 667 shares

Expires 2035-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method.

Read SEC document
June 16, 2026 Filed Jun 16, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionOption to Purchase Common Stock · Derivative 1,000 $61.22 Strike: $61.22 $61,220.00
Disclosure

SEC source: 0001482442-26-000012 · form4-06162026_040603.xml · derivative · entry 7

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,415

Underlying: Common Stock · 1,000 shares

Expires 2034-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method.

Read SEC document
June 16, 2026 Filed Jun 16, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionOption to Purchase Common Stock · Derivative 1,666 $39.47 Strike: $39.47 $65,757.02
Disclosure

SEC source: 0001482442-26-000012 · form4-06162026_040603.xml · derivative · entry 6

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,415

Underlying: Common Stock · 1,666 shares

Expires 2033-04-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method.

Read SEC document
June 16, 2026 Filed Jun 16, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 SaleCommon Stock 1,880 $707.35 $1,329,818.00
Disclosure

SEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 5

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,005

F5 · shares: On June 16, 2026 the Reporting Person sold 1,880 shares of the Issuer's common stock on the open market at an average price of $707.35 per share.

Read SEC document
June 16, 2026 Filed Jun 16, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 430 $148.72 $63,949.60
Disclosure

SEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method.

Read SEC document
June 16, 2026 Filed Jun 16, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 588 $61.22 $35,997.36
Disclosure

SEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,455

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method.

Read SEC document
June 16, 2026 Filed Jun 16, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 862 $39.47 $34,023.14
Disclosure

SEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,867

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 SaleCommon Stock 9,993 $651.22 $6,507,641.46
Disclosure

SEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,005

F1 · shares: On June 15, 2026, the Reporting Person sold 9,993 shares of the Issuer's common stock on the open market at an average price of $651.22 per share.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionPerformance-Based Restricted Stock Units · Derivative 5,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 11

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,284

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 10,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 5,000.

F5 · derivative.expiration_date: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 10,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 5,000.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionEarnings Per Share Performance-Based Restricted Stock Units · Derivative 10,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 10

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,839

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 10,000.

F4 · derivative.expiration_date: Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 10,000.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionTime-Based Restricted Stock Units · Derivative 4,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 9

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,252

Underlying: Common Stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends.

F3 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 SaleCommon Stock 19,310 $602.11 $11,626,744.10
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 6

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,998

F6 · shares: On April 17, 2026, the Reporting Person sold 19,310 shares of the Issuer's common stock on the open market at an average price of $602.11 per share.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 5,756 $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 5

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 10,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 5,000.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 11,513 $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 10,000.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 2,302 $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,039

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionTime-Based Restricted Stock Units · Derivative 1,333 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 8

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,252

Underlying: Common Stock · 1,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionTime-Based Restricted Stock Units · Derivative 3,333 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 7

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,585

Underlying: Common Stock · 3,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 736 $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,737

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 21:00 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 1,869 $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative 3,339 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,839

Underlying: Common Stock · 3,339 shares

Expires not disclosed

F4 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,339 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 3,339 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

F4 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,339 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 3,339 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 GrantPerformance-Based Restricted Stock Units · Derivative 284 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,284

Underlying: Common Stock · 284 shares

Expires not disclosed

F3 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 284 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 284 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F3 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 284 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 284 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 GrantTime-Based Restricted Stock Units · Derivative 251 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,918

Underlying: Common Stock · 251 shares

Expires not disclosed

F2 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 251 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

F2 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 251 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC ARGAN INC AGX · Entity 3828 GrantOption to Purchase Common Stock · Derivative 415 $0.00 Strike: $588.28 $0.00
Disclosure

SEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,081

Underlying: Common Stock · 415 shares

Expires 2036-04-08

F1 · shares: On April 8, 2026, the Reporting Person received 10-year options to purchase 415 shares of the Issuer's common stock with an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 22:25 UTC ARGAN INC AGX · Entity 3828 SaleCommon Stock 559 $272.27 $152,198.93
Disclosure

SEC source: 0001482442-25-000006 · form4-10102025_101018.xml · nonDerivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Held in The David and Laura Watson Foundation

Disclosed balance after: 0

F3 · shares: On October 9, 2025, the David and Laura Watson Foundation sold 559 shares of the Issuer's common stock on the open market at a price of $272.27 per share.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 22:25 UTC ARGAN INC AGX · Entity 3828 GiftCommon Stock 559 $0.00 $0.00
Disclosure

SEC source: 0001482442-25-000006 · form4-10102025_101018.xml · nonDerivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Held in The David and Laura Watson Foundation

Disclosed balance after: 559

Read SEC document
October 09, 2025 Filed Oct 10, 2025 22:25 UTC ARGAN INC AGX · Entity 3828 GiftCommon Stock 559 $0.00 $0.00
Disclosure

SEC source: 0001482442-25-000006 · form4-10102025_101018.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,132

F2 · shares: On October 9, 2025, the Reporting Person gifted 559 shares of the Issuer's common stock to the David and Laura Watson Foundation, a donor-advised fund administered by Raymond James Charitable.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 22:25 UTC ARGAN INC AGX · Entity 3828 SaleCommon Stock 4,441 $277.01 $1,230,201.41
Disclosure

SEC source: 0001482442-25-000006 · form4-10102025_101018.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,691

F1 · shares: On October 9, 2025, the Reporting Person sold 4,441 shares of the Issuer's common stock on the open market at an average price of $277.01 per share.

Read SEC document
June 11, 2025 Filed Jun 11, 2025 20:15 UTC ARGAN INC AGX · Entity 3828 SaleCommon Stock 17,969 $211.02 $3,791,818.38
Disclosure

SEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 5

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,132

F5 · shares: On June 11, 2025, the Reporting Person sold 17,969 shares of the Issuer's common stock on the open market at an average price of $211.02 per share.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 20:15 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionOption to Purchase Common Stock · Derivative 1,000 $61.22 Strike: $61.22 $61,220.00
Disclosure

SEC source: 0001415889-25-016659 · form4-06112025_040609.xml · derivative · entry 8

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,666

Underlying: Common Stock · 1,000 shares

Expires 2034-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On June 9, 2025, the Reporting Portion exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share, using the net settle method.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 20:15 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionOption to Purchase Common Stock · Derivative 3,334 $39.47 Strike: $39.47 $131,592.98
Disclosure

SEC source: 0001415889-25-016659 · form4-06112025_040609.xml · derivative · entry 7

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,666

Underlying: Common Stock · 3,334 shares

Expires 2033-04-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On June 9, 2025, the Reporting Person exercised a portion of his stock option awarded on April 17, 2023 to purchase 3,334 shares of the Issuer's common stock at a price of $39.47 per share, using the net settle method.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 20:15 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionOption to Purchase Common Stock · Derivative 3,334 $36.78 Strike: $36.78 $122,624.52
Disclosure

SEC source: 0001415889-25-016659 · form4-06112025_040609.xml · derivative · entry 6

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 3,334 shares

Expires 2032-04-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 9, 2025 the Reporting Person exercised the remaining portion of his stock option awarded on April 18, 2022 to purchase 3,334 shares of the Issuer's common stock at a price of $36.78 per share, using the net settle method.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 20:15 UTC ARGAN INC AGX · Entity 3828 SaleCommon Stock 2,031 $230.38 $467,901.78
Disclosure

SEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,101

F4 · shares: On June 9, 2025, the Reporting Person sold 2,031 shares of the Issuer's common stock on the open market at an average price of $230.38 per share.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 20:15 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 410 $61.22 $25,100.20
Disclosure

SEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On June 9, 2025, the Reporting Portion exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share, using the net settle method.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 20:15 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 1,533 $39.47 $60,507.51
Disclosure

SEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,722

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On June 9, 2025, the Reporting Person exercised a portion of his stock option awarded on April 17, 2023 to purchase 3,334 shares of the Issuer's common stock at a price of $39.47 per share, using the net settle method.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 20:15 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 1,553 $36.78 $57,119.34
Disclosure

SEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 9, 2025 the Reporting Person exercised the remaining portion of his stock option awarded on April 18, 2022 to purchase 3,334 shares of the Issuer's common stock at a price of $36.78 per share, using the net settle method.

Read SEC document
April 18, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionPerformance-Based Restricted Stock Units · Derivative 10,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 13

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000.

F4 · derivative.expiration_date: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000.

Read SEC document
April 18, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionTime-Based Restricted Stock Units · Derivative 3,334 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 12

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,667

Underlying: Common Stock · 3,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025.

F3 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025.

Read SEC document
April 18, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 11,745 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 5

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000.

Read SEC document
April 18, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 1,958 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025.

Read SEC document
April 17, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionTime-Based Restricted Stock Units · Derivative 4,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 11

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,001

Underlying: Common Stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.

F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.

Read SEC document
April 17, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 2,286 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.

Read SEC document
April 16, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative 7,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 10

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,500

Underlying: Common Stock · 7,500 shares

Expires not disclosed

F8 · derivative.exercise_date: On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 7,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 7,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

F8 · derivative.expiration_date: On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 7,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 7,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

Read SEC document
April 16, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 GrantPerformance-Based Restricted Stock Units · Derivative 3,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 9

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 3,000 shares

Expires not disclosed

F7 · derivative.exercise_date: On April 16, 2025, the Reporting Person was granted PRSUs in the target number of 3,000 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 3,000 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F7 · derivative.expiration_date: On April 16, 2025, the Reporting Person was granted PRSUs in the target number of 3,000 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 3,000 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

Read SEC document
April 16, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 GrantOption to Purchase Common Stock · Derivative 2,000 $0.00 Strike: $148.72 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 8

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,334

Underlying: Common Stock · 2,000 shares

Expires 2035-04-16

F6 · shares: On April 16, 2025, the Reporting Person received 10-year options to purchase 2,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026.

Read SEC document
April 16, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 GrantTime-Based Restricted Stock Units · Derivative 4,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 7

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,001

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F5 · derivative.exercise_date: On April 16, 2025 the Reporting Person was granted TRSUs covering 4,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026.

F5 · derivative.expiration_date: On April 16, 2025 the Reporting Person was granted TRSUs covering 4,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026.

Read SEC document
April 16, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionTime-Based Restricted Stock Units · Derivative 3,333 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 6

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,001

Underlying: Common Stock · 3,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.

F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.

Read SEC document
April 16, 2025 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionCommon Stock 1,856 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.

Read SEC document
December 23, 2024 Filed Apr 21, 2025 20:41 UTC ARGAN INC AGX · Entity 3828 SaleCommon Stock 500 $139.89 $69,945.00
Disclosure

SEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Held in The David and Laura Watson Foundation

Disclosed balance after: 0

Read SEC document
December 18, 2024 Filed Dec 20, 2024 21:15 UTC ARGAN INC AGX · Entity 3828 Exercise / conversionOption to Purchase Common Stock · Derivative 40,000 $64.25 Strike: $64.25 $2,570,000.00
Disclosure

SEC source: 0001415889-24-029969 · form4-12202024_041201.xml · derivative · entry 5

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,334

Underlying: Common Stock · 40,000 shares

Expires 2027-04-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 18, 2024, the Reporting Person exercised his stock option awarded on April 6, 2017 to purchase 40,000 shares of the Issuer's common stock at a price of $64.25 per share, using the net settle method.

Read SEC document
December 18, 2024 Filed Dec 20, 2024 21:15 UTC ARGAN INC AGX · Entity 3828 GiftCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-029969 · form4-12202024_041201.xml · nonDerivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,791

F3 · shares: On December 18, 2024, the Reporting Person gifted 500 shares of the Issuer's common stock to the David and Laura Watson Foundation.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.